Ultrafiltration Membranes Enhanced with Electrospun Nanofibers Exhibit Improved Flux and Fouling Resistance.

In this study, we have improved membrane performance by enhancing ultrafiltration membranes with electrospun nanofibers. The high-porosity nanofiber layer provides a tailorable platform that does not affect the base membrane structure. To decouple the effects that nanofiber chemistry and morphology have on membrane performance, two polymers commonly used in the membrane industry, cellulose and polysulfone, were electrospun into a layer that was 50 µm thick and consisted of randomly accumulated 1-µm-diameter fibers. Fouling resistance was improved and selectivity was retained by ultrafiltration membranes enhanced with a layer of either cellulose or polysulfone nanofibers. Potentially because of their better mechanical integrity, the polysulfone nanofiber-membranes demonstrated a higher pure-water permeance across a greater range of transmembrane pressures than the cellulose nanofiber-membranes and control membranes. This work demonstrates that nanofiber-enhanced membranes hold potential as versatile materials platforms for improving the performance of ultrafiltration membranes.

Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.

Peripheral neuropathy is a common, irreversible complication of diabetes. We investigated whether gene transfer of an engineered zinc finger protein transcription factor (ZFP-TF) designed to upregulate expression of the endogenous vascular endothelial growth factor (VEGF)-A gene could protect against experimental diabetic neuropathy. ZFP-TF-driven activation of the endogenous gene results in expression of all of the VEGF-A isoforms, a fact that may be of significance for recapitulation of the proper biological responses stimulated by this potent neuroprotective growth factor. We show here that this engineered ZFP-TF activates VEGF-A in appropriate cells in culture and that the secreted VEGF-A protein induced by the ZFP protects neuroblastoma cell lines from a serum starvation insult in vitro. Importantly, single and repeat intramuscular injections of formulated plasmid DNA encoding the VEGF-A-activating ZFP-TF resulted in protection of both sensory and motor nerve conduction velocities in a streptozotocin-induced rat model of diabetes. These data suggest that VEGF-A-activating ZFP-TFs may ultimately be of clinical utility in the treatment of this disease.